Intervention Review

Alprazolam for depression

  1. Harm van Marwijk1,*,
  2. Gideon Allick1,
  3. Froukje Wegman1,
  4. Arjan Bax1,
  5. Ingrid I Riphagen2

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 11 JUL 2012

Assessed as up-to-date: 16 FEB 2012

DOI: 10.1002/14651858.CD007139.pub2


How to Cite

van Marwijk H, Allick G, Wegman F, Bax A, Riphagen II. Alprazolam for depression. Cochrane Database of Systematic Reviews 2012, Issue 7. Art. No.: CD007139. DOI: 10.1002/14651858.CD007139.pub2.

Author Information

  1. 1

    VU University Medical Center, Department of General Practice, EMGO Institute for Health and Care Research, Amsterdam, Netherlands

  2. 2

    Norwegian University of Science and Technology, Unit for Applied Clinical Research, Faculty of Medicine, Trondheim, Norway

*Harm van Marwijk, Department of General Practice, EMGO Institute for Health and Care Research, VU University Medical Center, PO Box 7057, Amsterdam, 1007 MB, Netherlands. hwj.vanmarwijk@vumc.nl. Harmvanmarwijk@hetnet.nl.

Publication History

  1. Publication Status: New
  2. Published Online: 11 JUL 2012

SEARCH

  1. Current Version

    Alprazolam for depression

    Harm van Marwijk, Gideon Allick, Froukje Wegman, Arjan Bax and Ingrid I Riphagen

    Article first published online: 11 JUL 2012 | DOI: 10.1002/14651858.CD007139.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Alprazolam for depression

    Harm van Marwijk and Arjan Bax

    Article first published online: 23 APR 2008 | DOI: 10.1002/14651858.CD007139